● Recruiting

Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer

Condition: Gastric Cancer · Sponsor: Ruijin Hospital

PhaseNA

Planned participants40

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

This study intends to explore the value of 68Ga-FAPI-04 and 18F-FDG PET/CT in the evaluation of treatment response to neoadjuvant chemotherapy(NAC) for patients with locally advanced gastric cancer(LAGC).

This description comes directly from the study's public registry record.

Talk to the study team

Ying Miao · 0086-13671921521 · myada821@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Ruijin Hospital

Shanghai, Shanghai Municipality, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05140746